Hawaii Subject | Access to Care | Senate | Introduced

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
HISB49Intro
25%
Authorizes manufacturers of investigational drugs or biological products that are pending approval by the United States Food and Drug Administration to make the drugs or products available to terminally ill patients under certain conditions. Effectiv...
[Detail][Text][Discuss]
2025-01-16
To Senate Health and Human Services Committee
Syndicate content
feedback